What is iRhythm Holdings, Inc. 's market cap?

iRhythm Holdings, Inc. (IRTC) has a market capitalization of $3.7B and trades on NASDAQ.

What is iRhythm Holdings, Inc. 's revenue and profitability?

iRhythm Holdings, Inc. generated $787.9M in trailing twelve-month revenue with a net loss of $64.1M, representing a net margin of -7.3%. Gross margin stands at 71.0%, with free cash flow of $18.8M. These figures are based on the Q1 2026 filing.

Who are iRhythm Holdings, Inc. 's competitors?

iRhythm Holdings, Inc. 's key competitors include Boston Scientific Corporation, BioTelemetry, Inc., Baxter International Inc., and others. These companies compete in similar markets and product categories.

Who does iRhythm Holdings, Inc. partner with?

iRhythm Holdings, Inc. 's notable partners include BioIS.

Where is iRhythm Holdings, Inc. headquartered?

iRhythm Holdings, Inc. is headquartered in United States of America and employs approximately 2,000 people. It has been publicly traded since 2016.

iRhythm Holdings, Inc.

IRTC

iRhythm Holdings is a leading digital healthcare company that specializes in remote cardiac monitoring and diagnostic solutions.

Market cap

$3.69B-17.6%

Revenue$787.9M+27.4%

Net income-$64.1M+43.5%

Free cash flow$18.8M+116%

EPS (diluted)-$2.00+45.1%

Trailing twelve months · change vs. prior year

Table of contents

Earnings

Q1 2026 report

April 30, 2026

Revenue$199.4MBeat by $5.3M EPS-$0.35Beat by $0.21

Read the full report

Next report

Aug 6, 2026 (In 1 week)

Revenue estimate$219.3M

EPS estimate-$0.01

Financials

Q1 2026

Income statement

See full

Revenue$199.4M+25.7%

Gross profit$141.4M+29.4%

Operating income-$16.2M+50.3%

Net income-$13.9M+54.6%

EPS (diluted)-$0.43+55.7%

Balance sheet

See full

Cash & equivalents$248.5M-35.2%

Total debt$79.0M-10.5%

Total equity$161.2M+86.0%

Total assets$1.0B+8.7%

Cash flow

See full

Operating cash flow-$26.2M-232%

CapEx$6.9M-26.7%

Free cash flow-$33.1M-91.1%

Valuation & ratios

Valuation

See full

Market cap$3.69B-17.6%

Enterprise value$3.52B-15.2%

P/S4.7×-2.0×

Profitability

See full

Gross margin71%+1.6pp

Operating margin-5.5%-2.2pp

FCF margin2.4%—

Returns & leverage

See full

Debt / equity0.5×-0.5×

Current ratio5.2×-0.5×

Segments

By product

See full

Contracted third-party payors$106.8M+27.4%

CMS$51.4M—

Customer A$30.2M+13.1%

Non-contracted third-party payors$11.0M+9.4%

Competitors

By market cap

Medtronic$107.81B-8.5%

Boston Scientific$67.6B-56.8%

Philips$24.3B+2.4%

Baxter International$12.1B-17.6%

iRhythm Holdings, Inc. $3.7B-15.8%

Owlet$152.0M+8.6%

Heartbeam, Inc.$29.1M-32.7%

Heart Test Laboratories, Inc.$8.3M+30.8%

By revenue growth

iRhythm Holdings, Inc. +27.4%

Owlet+26.8%

Boston Scientific+13.5%

Medtronic+8.4%

Baxter International+5.1%

By net margin

Boston Scientific17.48%+4.0pp

Medtronic13.2%-0.7pp

iRhythm Holdings, Inc. -7.32%+10.2pp

Baxter International-9.7%-4.5pp

Owlet-43.0%-27.9pp

Profile

iRhythm Holdings is a leading digital healthcare company that specializes in remote cardiac monitoring and diagnostic solutions. The company leverages a proprietary cloud-based data platform and wearable biosensing technology to provide clinical-grade data and analytics for heart rhythm disorders. Their core value proposition centers on improving clinical outcomes and diagnostic yield through long-term continuous monitoring and advanced artificial intelligence.

Competitive position

A leading provider of long-term continuous cardiac monitoring utilizing proprietary AI and wearable biosensor technology.

GeographiesUnited States, Philippines

Customer segmentsHealthcare Providers, Health Systems, Payors

Business modelService-based medical device, AI-as-a-Service, Healthcare reimbursement

SuppliersSemiconductor manufacturers, Biosensor component suppliers, Cloud infrastructure providers, Third-party clinical service vendors

CustomersCardiologists, Electrophysiologists, Primary care physicians, Commercial insurance payors, Government payors (Medicare/Medicaid)

CountryUnited States of America

Listed2016

Employees2.0K

CEOQuentin S. Blackford

SectorHealthcare

IndustryMedical - Devices

Websiteirhythmtech.com

FilingsSEC EDGAR

Ask your AI about iRhythm Holdings, Inc. .

Connect your AI assistant and dig into the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is iRhythm Holdings, Inc. 's market cap?: iRhythm Holdings, Inc. (IRTC) has a market capitalization of $3.7B and trades on NASDAQ.
What is iRhythm Holdings, Inc. 's revenue and profitability?: iRhythm Holdings, Inc. generated $787.9M in trailing twelve-month revenue with a net loss of $64.1M, representing a net margin of -7.3%. Gross margin stands at 71.0%, with free cash flow of $18.8M. These figures are based on the Q1 2026 filing.
Who are iRhythm Holdings, Inc. 's competitors?: iRhythm Holdings, Inc. 's key competitors include Boston Scientific Corporation, BioTelemetry, Inc., Baxter International Inc., and others. These companies compete in similar markets and product categories.
Who does iRhythm Holdings, Inc. partner with?: iRhythm Holdings, Inc. 's notable partners include BioIS.
Where is iRhythm Holdings, Inc. headquartered?: iRhythm Holdings, Inc. is headquartered in United States of America and employs approximately 2,000 people. It has been publicly traded since 2016.